Form 4: Cryoport Executive Executes Stock Option Exercise and Sale

Chief Digital and Tech Officer Edward J. Zecchini exercised options and sold 35,000 shares of Cryoport, Inc. common stock.

Summary

• Edward J. Zecchini, Chief Digital and Tech Officer of Cryoport, Inc., exercised stock options for 35,000 shares at an exercise price of $4.80 per share.
• The transactions occurred on June 10 and June 11, 2026.
• Following the exercise, the reporting person sold the acquired shares at weighted average prices of $15.2314 and $14.4714 per share.
• The reporting person's total beneficial ownership of common stock remains at 109,719 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents routine executive equity management rather than a strategic shift or signal of financial distress.

Positives

• The executive maintains a significant equity stake of 109,719 shares in the company.
• The exercise of options demonstrates long-term alignment with the company's equity incentive programs.

Negatives

• The transaction resulted in the immediate sale of all 35,000 shares acquired through the option exercise.

Risks

• Market volatility may impact the value of remaining holdings.
• Future sales by insiders could influence market perception of the stock.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling following option exercises is a standard liquidity event for corporate executives and does not necessarily reflect a change in sentiment regarding the company's long-term prospects.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for executive compensation and equity management.
• The sale of shares acquired via options is a common practice among executives in the life sciences and logistics sectors.

Stakeholder Impact

• Minimal impact on shareholders as the transaction reflects individual financial planning by an executive.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Cryoport, CYRX, Insider Trading, Form 4, Stock Options, Biotech Logistics